According to The New York Times, OpenAI opened its first lobbying office, "Workshop," in Washington, D.C., just blocks from the White House, this week to advocate for policies such as expanding data center infrastructure and enabling free use of copyrighted content. In the first quarter of 2026, OpenAI’s federal lobbying expenditures reached $1 million, doubling year-over-year. Competitor Anthropic also opened an office in Washington in April this year, with its lobbying spending increasing tenfold year-over-year to $3 million last year. Meanwhile, Meta, Nvidia, and Alphabet collectively spent $47.8 million on lobbying last year, a 22% increase from the previous year. According to the citizen oversight group Public Citizen, one-quarter of all federal lobbyists in Washington are now involved in AI-related issues, up significantly from 11% in 2023.
OpenAI Opens First Washington Office as AI Lobbying Spending Surges
TechFlowShare
Summary
OpenAI has opened its first Washington office, "Workshop," near the White House as AI lobbying spending rises. In Q1 2026, OpenAI spent $1 million on federal lobbying, double the previous year. Anthropic opened a D.C. office in April 2026, with 2025 lobbying expenses reaching $3 million. Meta, Nvidia, and Alphabet spent $47.8 million in 2025, a 22% increase. Altcoins to watch may respond to regulatory shifts. Public Citizen reports that a quarter of federal lobbyists now focus on AI, up from 11% in 2023. Inflation data could also influence market reactions to policy changes.
Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information.
Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.